- ICH GCP
- EU Clinical Trials Registry
Latest Trials
EudraCT Number: 2004-003985-14 | Sponsor Protocol Number: CPR-EFC5816-EN-E01 | Start Date: 2005-05-23 | |||||||||||
Sponsor Name: Sanofi-Synthelabo Research | |||||||||||||
Full Title: A Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial Evaluating the Effect of Two Doses of a Vasopressin V2 Receptor Antagonist (SR121463B) on Serum Sodium in Patients with Dilutional ... | |||||||||||||
Medical condition: Dilutional hyponatremia excluding chronic syndrome of inappropriate antidiuretic hormone secretion (SIADH) or cirrhosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) BE (Completed) SE (Completed) DK (Completed) | |||||||||||||
Trial results: View results |